DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 38 filers reported holding DEPOMED INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $89,000 | +93.5% | 121,000 | +95.2% | 0.00% | – |
| Q3 2019 | $46,000 | +21.1% | 62,000 | +10.7% | 0.00% | – |
| Q4 2018 | $38,000 | -97.7% | 56,000 | -97.3% | 0.00% | -100.0% |
| Q2 2018 | $1,680,000 | +3.3% | 2,056,000 | +2.8% | 0.00% | +100.0% |
| Q1 2018 | $1,626,000 | +285.3% | 2,000,000 | +300.0% | 0.00% | – |
| Q4 2017 | $422,000 | +1355.2% | 500,000 | +1182.1% | 0.00% | – |
| Q3 2017 | $29,000 | -99.2% | 39,000 | -99.1% | 0.00% | -100.0% |
| Q2 2017 | $3,862,000 | -10.1% | 4,401,000 | -4.3% | 0.00% | -25.0% |
| Q1 2017 | $4,296,000 | +30.8% | 4,601,000 | +59.5% | 0.00% | +33.3% |
| Q4 2016 | $3,284,000 | -40.6% | 2,884,000 | -25.7% | 0.00% | -40.0% |
| Q3 2016 | $5,530,000 | +40.2% | 3,884,000 | +18.9% | 0.01% | +25.0% |
| Q2 2016 | $3,943,000 | +43711.1% | 3,267,000 | +40737.5% | 0.00% | – |
| Q4 2015 | $9,000 | -98.5% | 8,000 | -98.4% | 0.00% | -100.0% |
| Q3 2015 | $595,000 | -57.7% | 500,000 | -54.4% | 0.00% | 0.0% |
| Q2 2015 | $1,406,000 | +8687.5% | 1,097,000 | +9041.7% | 0.00% | – |
| Q1 2015 | $16,000 | -99.2% | 12,000 | -99.4% | 0.00% | -100.0% |
| Q4 2014 | $2,057,000 | +199.9% | 1,906,000 | +193.2% | 0.00% | +100.0% |
| Q3 2014 | $686,000 | – | 650,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|